Factor V Leiden genotype frequencies
| . | Control . | Myocardial infarction . | Ischemic stroke . | Non-MI ischemic heart disease . | |||
|---|---|---|---|---|---|---|---|
| CCHS . | Patients . | CCHS . | Patients . | CCHS . | Patients . | CCHS . | |
| Wild-type | 7278 (92.0) | 445 (90.3) | 438 (93.4) | 214 (92.6) | 387 (94.4) | 412 (92.0) | 337 (92.3) |
| Heterozygote | 612 (7.7) | 47 (9.5) | 30 (6.4) | 16 (6.9) | 22 (5.4) | 34 (7.6) | 26 (7.1) |
| Homozygote | 17 (0.2) | 1 (0.2) | 1 (0.2) | 1 (0.4) | 1 (0.2) | 2 (0.4) | 2 (0.5) |
| χ-square test | — | P = .36 | P = .57 | P = .71 | P = .21 | P = .60 | P = .39 |
| . | Control . | Myocardial infarction . | Ischemic stroke . | Non-MI ischemic heart disease . | |||
|---|---|---|---|---|---|---|---|
| CCHS . | Patients . | CCHS . | Patients . | CCHS . | Patients . | CCHS . | |
| Wild-type | 7278 (92.0) | 445 (90.3) | 438 (93.4) | 214 (92.6) | 387 (94.4) | 412 (92.0) | 337 (92.3) |
| Heterozygote | 612 (7.7) | 47 (9.5) | 30 (6.4) | 16 (6.9) | 22 (5.4) | 34 (7.6) | 26 (7.1) |
| Homozygote | 17 (0.2) | 1 (0.2) | 1 (0.2) | 1 (0.4) | 1 (0.2) | 2 (0.4) | 2 (0.5) |
| χ-square test | — | P = .36 | P = .57 | P = .71 | P = .21 | P = .60 | P = .39 |
Values represent number of individuals and percentages in parenthesis. Chi-square test versus controls using 2 × 3 tables.
CCHS indicates The Copenhagen City Heart Study; MI, myocardial infarction.